- Companies
- Norson Biotechnology
Norson Biotechnology Funding, Investors & Competitors
Norson Biotechnology has raised $133M across 2 funding rounds, most recently a $71M Series B in June 2020.
Last Norson Biotechnology funding round
$71M
Series B · Jun 2020
Cumulative funding Norson Biotechnology raised
$133M
across 2 funding rounds
Key investors in Norson Biotechnology
OrbiMed
DT Capital Partners
Horus Capital
Zhuhai Huajin Capital Co
China Merchants Securities
Sunshine Insurance Group
Qiandao Fund
Ligong investment
Norson Biotechnology Overview
About Norson Biotechnology
Norson Biotechnology is a Chinese firm producing probiotic health products. It manufactures edible probiotic powders, solid beverages, and fermented lactic acid bacteria drinks for digestive and immune support. The portfolio targets consumer wellness through functional foods distributed in Asia.
Founded
2018
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Product sales
Norson Biotechnology Funding History
Norson Biotechnology has raised a total of $133M across 2 funding rounds.
Norson Biotechnology's first fundraising round was a $62M Series A in January 2018. The most recent completed round was a $71M Series B in June 2020.
Norson Biotechnology funding rounds
| Date | Stage | Investors | Raised |
|---|---|---|---|
| Jun 2020 | Series B | DT Capital Partners (lead); Sunshine Insurance Group; Yuanchuang Investment Management; Qiandao Fund; Zhuhai Huajin Capital Co; Yantai Financial Investment Holding; OrbiMed; Horus Capital; Ligong investment; China Merchants Securities; Xinzhen Tianying Fund | $71M |
| Jan 2018 | Series A | - | $62M |
Who has invested in Norson Biotechnology?
11 investors have backed Norson Biotechnology across its funding rounds, including OrbiMed, DT Capital Partners, Horus Capital, Zhuhai Huajin Capital Co, China Merchants Securities and Sunshine Insurance Group.
Lead investors include DT Capital Partners.
Norson Biotechnology Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 1 | Participant | Jun 2020 | ||
| 1 | Participant | Jun 2020 | ||
| 1 | Participant | Jun 2020 | ||
| 1 | Lead | Jun 2020 | ||
| 1 | Participant | Jun 2020 | ||
| -- | 1 | Participant | Jun 2020 | |
| 1 | Participant | Jun 2020 | ||
| 1 | Participant | Jun 2020 | ||
| 1 | Participant | Jun 2020 | ||
This data is available for Pro users. Sign up to see all 11 Norson Biotechnology investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialNorson Biotechnology Competitors
Norson Biotechnology competitors include listed companies like Divi's Laboratories, Yunnan Baiyao Group, Zhejiang NHU and Hebei Yangyuan Zhihui, and private ones like Impossible Foods and L&P Cosmetic.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $1.1B | $374M | $26B | 21.2x | ||
| Publicly listed | $6.1B | $945M | $14B | 1.9x | ||
| Publicly listed | $3.3B | $1.5B | $12B | 3.1x | ||
| Publicly listed | $796M | $254M | $8.1B | 8.4x | ||
| Private | $460M | - | $7B | 15.2x | ||
| Private | - | - | $1.1B | - |
Norson Biotechnology Public Comps
Norson Biotechnology is still privately-owned, but its public comps include Coca-Cola, Nestlé, PepsiCo, AB InBev, Unilever, Monster Beverage, Mondelez, Nongfu Spring, Hindustan Unilever and Coca-Cola Europacific Partners.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $48B | $18B | 8.5x | 8.3x | 22.8x | 24.1x | |||
| $109B | $19B | 2.9x | 2.8x | 16.2x | 14.4x | |||
| $94B | $16B | 2.4x | 2.3x | 14.5x | 11.8x | |||
| $59B | $20B | 3.9x | 3.6x | 11.7x | 10.0x | |||
| $58B | $12B | 2.9x | 2.8x | 13.6x | 12.4x | |||
| $8.3B | $2.5B | 10.1x | 9.0x | 33.3x | 28.9x | |||
| $39B | $4.7B | 2.6x | 2.5x | 21.4x | 14.9x | |||
| $7.8B | $3.5B | 6.9x | 6.3x | 15.2x | 14.0x | |||
This data is available for Pro users. Sign up to see all Norson Biotechnology competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Norson Biotechnology
| When was Norson Biotechnology founded? | Norson Biotechnology was founded in 2018. |
| Where is Norson Biotechnology headquartered? | Norson Biotechnology is headquartered in Qingdao, China. |
| Is Norson Biotechnology publicly listed? | No, Norson Biotechnology is a private, VC-backed company. |
| How much funding has Norson Biotechnology raised? | Norson Biotechnology has raised $133M across 2 funding rounds. |
| What was Norson Biotechnology's last funding round? | Norson Biotechnology's last funding round was a $71M Series B in June 2020, led by DT Capital Partners. |
| Who are Norson Biotechnology's investors? | Norson Biotechnology's investors include Sunshine Insurance Group, Yuanchuang Investment Management, Qiandao Fund, DT Capital Partners, Zhuhai Huajin Capital Co, Yantai Financial Investment Holding, OrbiMed, Horus Capital, Ligong investment, China Merchants Securities and 1 other. |
| Which companies are comparable to Norson Biotechnology? | Companies comparable to Norson Biotechnology include Divi's Laboratories, Yunnan Baiyao Group, Zhejiang NHU, Hebei Yangyuan Zhihui, Impossible Foods and L&P Cosmetic. |
See companies similar to Norson Biotechnology
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




